Clinical Trial

Multi-target TMS for Schizophrenia Negative Symptoms

Name: Multi-target TMS for Schizophrenia Negative Symptoms — clinical trial record (NCT07559084)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the left dorsolateral prefrontal cortex (L-DLPFC), left inferior parietal lobule (L-IPL), and right orbitofrontal cortex (R-OFC) for negative symptoms of schizophrenia.

Trial Details

NCT Number	NCT07559084
Lead Sponsor	Shanghai Mental Health Center
Conditions	SCHIZOPHRENIA 1 (Disorder)
Enrollment	64 participants
Start Date	2026-05-01
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-01-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-30